Literature DB >> 22450771

[Medicinal or instrumental (corrected) therapy of renal artery stenosis?].

L C Rump1, L Sellin.   

Abstract

Arteriosclerotic renal artery stenosis (RAS) has an increased incidence in patients with cardiovascular risk factors. Clinically RAS presents in some patients as secondary, sometimes resistant arterial hypertension and in others as chronic renal insufficiency, sometimes with acute renal failure and in a third group both symptoms are observed. Doppler ultrasound plays a central role in the diagnosis of RAS. Therapeutically, it is important to identify hemodynamically relevant RAS before interventional therapy is initiated. The therapy of RAS has been under intensive debate since the publication of randomized controlled trials (RCT) which showed that only a subset of RAS can be successfully treated by interventional therapy. Since then the medicinal therapy of RAS has gained more and more impact. The following questions are raised: which forms of RAS can be treated by which therapy? What is the best medicinal therapy to treat RAS? What substances are recommended?

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22450771     DOI: 10.1007/s00108-012-3038-1

Source DB:  PubMed          Journal:  Internist (Berl)        ISSN: 0020-9554            Impact factor:   0.743


  27 in total

1.  Kiss my astral: one seriously flawed study of renal stenting after another.

Authors:  Christopher J White
Journal:  Catheter Cardiovasc Interv       Date:  2010-02-01       Impact factor: 2.692

2.  Left ventricular morphology and function in patients with atherosclerotic renovascular disease.

Authors:  Julian R Wright; Ala'a E Shurrab; Anne Cooper; Paul R Kalra; Robert N Foley; Philip A Kalra
Journal:  J Am Soc Nephrol       Date:  2005-07-27       Impact factor: 10.121

3.  Renal artery stenosis: prevalence and associated risk factors in patients undergoing routine cardiac catheterization.

Authors:  M B Harding; L R Smith; S I Himmelstein; K Harrison; H R Phillips; S J Schwab; J B Hermiller; C J Davidson; T M Bashore
Journal:  J Am Soc Nephrol       Date:  1992-05       Impact factor: 10.121

4.  What is critical renal artery stenosis? Implications for treatment.

Authors:  G Simon
Journal:  Am J Hypertens       Date:  2000-11       Impact factor: 2.689

5.  Prevalence of atherosclerotic renal artery stenosis in patients with atherosclerosis elsewhere.

Authors:  J W Olin; M Melia; J R Young; R A Graor; B Risius
Journal:  Am J Med       Date:  1990-01       Impact factor: 4.965

6.  Angiotensin inhibition in renovascular disease: a population-based cohort study.

Authors:  Daniel G Hackam; Minh L Duong-Hua; Muhammad Mamdani; Ping Li; Sheldon W Tobe; J David Spence; Amit X Garg
Journal:  Am Heart J       Date:  2008-07-21       Impact factor: 4.749

Review 7.  Drug-eluting stents in renal artery stenosis.

Authors:  M Zähringer; P M T Pattynama; A Talen; M Sapoval
Journal:  Eur Radiol       Date:  2007-10-11       Impact factor: 5.315

8.  ACC/AHA 2005 guidelines for the management of patients with peripheral arterial disease (lower extremity, renal, mesenteric, and abdominal aortic): executive summary a collaborative report from the American Association for Vascular Surgery/Society for Vascular Surgery, Society for Cardiovascular Angiography and Interventions, Society for Vascular Medicine and Biology, Society of Interventional Radiology, and the ACC/AHA Task Force on Practice Guidelines (Writing Committee to Develop Guidelines for the Management of Patients With Peripheral Arterial Disease) endorsed by the American Association of Cardiovascular and Pulmonary Rehabilitation; National Heart, Lung, and Blood Institute; Society for Vascular Nursing; TransAtlantic Inter-Society Consensus; and Vascular Disease Foundation.

Authors:  Alan T Hirsch; Ziv J Haskal; Norman R Hertzer; Curtis W Bakal; Mark A Creager; Jonathan L Halperin; Loren F Hiratzka; William R C Murphy; Jeffrey W Olin; Jules B Puschett; Kenneth A Rosenfield; David Sacks; James C Stanley; Lloyd M Taylor; Christopher J White; John White; Rodney A White; Elliott M Antman; Sidney C Smith; Cynthia D Adams; Jeffrey L Anderson; David P Faxon; Valentin Fuster; Raymond J Gibbons; Jonathan L Halperin; Loren F Hiratzka; Sharon A Hunt; Alice K Jacobs; Rick Nishimura; Joseph P Ornato; Richard L Page; Barbara Riegel
Journal:  J Am Coll Cardiol       Date:  2006-03-21       Impact factor: 24.094

9.  Factors affecting long-term survival following renal artery stenting.

Authors:  Mark C Bates; John E Campbell; Patrick A Stone; Michael R Jaff; Mike Broce; Philip S Lavigne
Journal:  Catheter Cardiovasc Interv       Date:  2007-06-01       Impact factor: 2.692

10.  RADAR - A randomised, multi-centre, prospective study comparing best medical treatment versus best medical treatment plus renal artery stenting in patients with haemodynamically relevant atherosclerotic renal artery stenosis.

Authors:  Uwe Schwarzwälder; Michael Hauk; Thomas Zeller
Journal:  Trials       Date:  2009-07-27       Impact factor: 2.279

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.